Expertise in
58
conditions

Bin Y. Wu

No. 89, Guhuai Road, 
Jining, CN 
Expertise in
58
conditions
No. 89, Guhuai Road, 
Jining, CN 
OverviewLocationsClinical Research

Overview

Bin Wu practices in Jining, China. Mr. Wu is highly rated in 58 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Nutcracker Syndrome (NCS), Necrosis, Colostomy, and Endoscopy.

His clinical research consists of co-authoring 2046 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

No. 89, Guhuai Road, Jining, 272029, China
Other Locations
461 Ba Yi Avenue, Nanchang, 330006, China
State Key Laboratory Of Materials Oriented Chemical Engineering, Nanjing, 211816, China
Huangpu Branch, Shanghai, China
No. 600 Tianhe Road, Guangzhou, 510630, China
No. 49, North Garden Street, Haidian, 100191, China
12 Middle Wulumuqi Road, Shanghai, 200040, China
Peking Union Medical College Hospital, Peking Union Medical College, Beijing, China
69 Yongding Road, Haidian, 100039, China
No. 135, Xingang Xi Road, Guangzhou, 510275, China
36 Sanhao Street, Shenyang, 110004, China
600 Tianhe Road, Guangzhou, 510630, China
No. 36, San Hao Street, Shenyang, 110004, China
No. 1 Jianshe East Road, Zhengzhou, 450052, China
Chang Le Xi Street #127, Xi'an, 710032, China
22 Shuangyong Road, Nanning, 530021, China
39 Huaxiang Road, Shenyang, 110000, China
N1, Shangcheng Road, Yiwu, China
No.163, Shoushan Rd, Jiangyin, 214400, China
Haikou Experimental Station, Haikou, China
No.37, Guoxue Lane, 610041, Chengdu, China
No. 600, Yishan Road, Shanghai, 200233, China
163 Shou Shan Road, Jiangyin, 214400, China
Wenhua Road 72, Shenyang, 110016, China
No. 12, Zhongguancun South Street, Beijing, 100081, China
5333 Xi'an Road, Changchun, 130062, China
No. 4365 Kang Xin Road, Shanghai, 201318, China
38 Guangji Road, Hangzhou, 310022, China
Changjiang East Road 60, Dalian, 116001, China
No. 101 Shanghai Road, Xuzhou, 221116, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Investigation of the Clinical, Radiological and Biological Factors Associated With Disease Progression, Phenotypes and Endotypes of COPD in China
Investigation of the Clinical, Radiological and Biological Factors Associated With Disease Progression, Phenotypes and Endotypes of COPD in China
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Other
A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
Enrollment Status: Completed
Publish Date: August 11, 2025
Intervention Type: Device, Drug
Study Drugs: FF/VI, FF/UMEC/VI
Study Phase: Phase 3
A Randomized, Double Blind, Parallel Group Study of the Efficacy and Safety of Mepolizumab as Adjunctive Therapy in Patients With Severe Asthma With Eosinophilic Inflammation
A Randomized, Double Blind, Parallel Group Study of the Efficacy and Safety of Mepolizumab as Adjunctive Therapy in Patients With Severe Asthma With Eosinophilic Inflammation
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drugs: Mepolizumab, Salbutamol
Study Phase: Phase 3
View 2 Less Clinical Trials

2046 Total Publications

Cardiotoxicity associated with antifungal agents: A pharmacovigilance analysis of the FDA Adverse Event Reporting System.
Cardiotoxicity associated with antifungal agents: A pharmacovigilance analysis of the FDA Adverse Event Reporting System.
Journal: International journal of clinical pharmacology and therapeutics
Published: December 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wu's expertise for a condition
ConditionClose
    View All 53 Advanced Conditions
    View All 277 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile